Cargando…

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens

MHC-I-associated peptides deriving from non-coding genomic regions and mutations can generate tumor-specific antigens, including neoantigens. Quantifying tumor-specific antigens’ RNA expression in malignant and benign tissues is critical for discriminating actionable targets. We present BamQuery, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuevas, Maria Virginia Ruiz, Hardy, Marie-Pierre, Larouche, Jean-David, Apavaloaei, Anca, Kina, Eralda, Vincent, Krystel, Gendron, Patrick, Laverdure, Jean-Philippe, Durette, Chantal, Thibault, Pierre, Lemieux, Sébastien, Perreault, Claude, Ehx, Grégory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426134/
https://www.ncbi.nlm.nih.gov/pubmed/37582761
http://dx.doi.org/10.1186/s13059-023-03029-1
_version_ 1785089991472316416
author Cuevas, Maria Virginia Ruiz
Hardy, Marie-Pierre
Larouche, Jean-David
Apavaloaei, Anca
Kina, Eralda
Vincent, Krystel
Gendron, Patrick
Laverdure, Jean-Philippe
Durette, Chantal
Thibault, Pierre
Lemieux, Sébastien
Perreault, Claude
Ehx, Grégory
author_facet Cuevas, Maria Virginia Ruiz
Hardy, Marie-Pierre
Larouche, Jean-David
Apavaloaei, Anca
Kina, Eralda
Vincent, Krystel
Gendron, Patrick
Laverdure, Jean-Philippe
Durette, Chantal
Thibault, Pierre
Lemieux, Sébastien
Perreault, Claude
Ehx, Grégory
author_sort Cuevas, Maria Virginia Ruiz
collection PubMed
description MHC-I-associated peptides deriving from non-coding genomic regions and mutations can generate tumor-specific antigens, including neoantigens. Quantifying tumor-specific antigens’ RNA expression in malignant and benign tissues is critical for discriminating actionable targets. We present BamQuery, a tool attributing an exhaustive RNA expression to MHC-I-associated peptides of any origin from bulk and single-cell RNA-sequencing data. We show that many cryptic and mutated tumor-specific antigens can derive from multiple discrete genomic regions, abundantly expressed in normal tissues. BamQuery can also be used to predict MHC-I-associated peptides immunogenicity and identify actionable tumor-specific antigens de novo. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03029-1.
format Online
Article
Text
id pubmed-10426134
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104261342023-08-16 BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens Cuevas, Maria Virginia Ruiz Hardy, Marie-Pierre Larouche, Jean-David Apavaloaei, Anca Kina, Eralda Vincent, Krystel Gendron, Patrick Laverdure, Jean-Philippe Durette, Chantal Thibault, Pierre Lemieux, Sébastien Perreault, Claude Ehx, Grégory Genome Biol Method MHC-I-associated peptides deriving from non-coding genomic regions and mutations can generate tumor-specific antigens, including neoantigens. Quantifying tumor-specific antigens’ RNA expression in malignant and benign tissues is critical for discriminating actionable targets. We present BamQuery, a tool attributing an exhaustive RNA expression to MHC-I-associated peptides of any origin from bulk and single-cell RNA-sequencing data. We show that many cryptic and mutated tumor-specific antigens can derive from multiple discrete genomic regions, abundantly expressed in normal tissues. BamQuery can also be used to predict MHC-I-associated peptides immunogenicity and identify actionable tumor-specific antigens de novo. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03029-1. BioMed Central 2023-08-15 /pmc/articles/PMC10426134/ /pubmed/37582761 http://dx.doi.org/10.1186/s13059-023-03029-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Method
Cuevas, Maria Virginia Ruiz
Hardy, Marie-Pierre
Larouche, Jean-David
Apavaloaei, Anca
Kina, Eralda
Vincent, Krystel
Gendron, Patrick
Laverdure, Jean-Philippe
Durette, Chantal
Thibault, Pierre
Lemieux, Sébastien
Perreault, Claude
Ehx, Grégory
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
title BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
title_full BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
title_fullStr BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
title_full_unstemmed BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
title_short BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
title_sort bamquery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
topic Method
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426134/
https://www.ncbi.nlm.nih.gov/pubmed/37582761
http://dx.doi.org/10.1186/s13059-023-03029-1
work_keys_str_mv AT cuevasmariavirginiaruiz bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT hardymariepierre bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT larouchejeandavid bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT apavaloaeianca bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT kinaeralda bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT vincentkrystel bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT gendronpatrick bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT laverdurejeanphilippe bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT durettechantal bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT thibaultpierre bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT lemieuxsebastien bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT perreaultclaude bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens
AT ehxgregory bamqueryaproteogenomictooltoexploretheimmunopeptidomeandprioritizeactionabletumorantigens